CLINICAL_TRIALS
trial_result
· 2012-08-17
Clinical Trial Update: Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas [Phase 2]
Summary
A Phase 2 trial of RAD001 (everolimus) in soft tissue extremity and retroperitoneal sarcomas was terminated; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Sarcoma | Phase 2 | Status: TERMINATED | Results posted: 2012-08-17